These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 11265361)

  • 21. Combination neurohormonal blockade with ACE inhibitors, angiotensin II antagonists and beta-blockers in patients with congestive heart failure: design of the Randomized Evaluation of Strategies for Left Ventricular Dysfunction (RESOLVD) Pilot Study.
    Tsuyuki RT; Yusuf S; Rouleau JL; Maggioni AP; McKelvie RS; Wiecek EM; Wang Y; Pogue J; Teo KK; White M; Avezum A; Latini R; Held P; Lindgren E; Probstfield J
    Can J Cardiol; 1997 Dec; 13(12):1166-74. PubMed ID: 9444298
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Role of angiotensin II in the evolution of diastolic heart failure.
    Chinnaiyan KM; Alexander D; McCullough PA
    J Clin Hypertens (Greenwich); 2005 Dec; 7(12):740-7. PubMed ID: 16330897
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The renin-angiotensin-aldosterone system and heart failure.
    Sayer G; Bhat G
    Cardiol Clin; 2014 Feb; 32(1):21-32, vii. PubMed ID: 24286576
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Which inhibitor of the renin-angiotensin system should be used in chronic heart failure and acute myocardial infarction?
    McMurray JJ; Pfeffer MA; Swedberg K; Dzau VJ
    Circulation; 2004 Nov; 110(20):3281-8. PubMed ID: 15545527
    [No Abstract]   [Full Text] [Related]  

  • 25. Role of angiotensin-converting enzyme inhibitors in congestive heart failure.
    Galvao M
    Heart Lung; 1990 Sep; 19(5 Pt 1):505-11. PubMed ID: 2211159
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Therapy of chronic left heart failure].
    Ertl G; Angermann CE
    Internist (Berl); 2007 Jan; 48(1):59-65; quiz 66-7. PubMed ID: 17171382
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Clinical significance of RAS block in heart diseases].
    Saito Y
    Nihon Naika Gakkai Zasshi; 2006 Sep; 95(9):1750-5. PubMed ID: 17037310
    [No Abstract]   [Full Text] [Related]  

  • 28. Novelties in Therapy of Chronic Heart Failure.
    Doimo S; Pavan D
    Heart Fail Clin; 2021 Apr; 17(2):255-262. PubMed ID: 33673949
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mechanistic and clinical rationales for using beta-blockers in heart failure.
    Bristow MR
    J Card Fail; 2000 Jun; 6(2 Suppl 1):8-14. PubMed ID: 10908093
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Do beta-blockers and inhibitors of the renin-angiotensin aldosterone system improve outcomes in patients with heart failure and left ventricular ejection fraction >40%?
    Lumbers RT; Martin N; Manoharan K; Thomas J; Davies LC
    Heart; 2019 Oct; 105(20):1533-1535. PubMed ID: 31345952
    [No Abstract]   [Full Text] [Related]  

  • 31. The role of the renin-angiotensin-aldosterone system in the management of heart failure.
    Rodgers JE; Patterson JH
    Pharmacotherapy; 2000 Nov; 20(11 Pt 2):368S-378S. PubMed ID: 11089708
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Upstream therapy for atrial fibrillation in heart failure.
    Goette A
    Heart Fail Clin; 2013 Oct; 9(4):417-25, viii. PubMed ID: 24054475
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A management programme for suspected heart failure in primary care in cooperation with specialists in cardiology.
    Mejhert M; Kahan T
    Eur J Gen Pract; 2015 Mar; 21(1):26-32. PubMed ID: 25342003
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Congestive heart failure, part 2: treatment].
    Smith JG; Kohl S; Kornhall B; Ekmehag B
    Lakartidningen; 2012 Oct 10-16; 109(41):1829-34. PubMed ID: 23173405
    [No Abstract]   [Full Text] [Related]  

  • 35. Overview of recent clinical trials in heart failure: what is the current standard of care?
    Murray DR; Dugan J
    Cardiol Rev; 2000; 8(6):340-7. PubMed ID: 11208254
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Left ventricular dysfunction: causes, natural history, and hopes for reversal.
    Armstrong PW
    Heart; 2000 Sep; 84 Suppl 1(Suppl 1):i15-7:discussion i50. PubMed ID: 10956313
    [No Abstract]   [Full Text] [Related]  

  • 37. [Neurohormonal mechanisms in congestive heart failure].
    Goch JH
    Pol Arch Med Wewn; 1992; 88(2-3):171-4. PubMed ID: 1492022
    [No Abstract]   [Full Text] [Related]  

  • 38. [Role of RAAS inhibitors for the treatment of heart failure].
    Murohara T
    Nihon Rinsho; 2012 Sep; 70(9):1577-81. PubMed ID: 23012806
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Left ventricular diastolic heart failure with normal left ventricular systolic function in older persons.
    Aronow WS
    J Lab Clin Med; 2001 May; 137(5):316-23. PubMed ID: 11329528
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Neurohormonal intervention to reduce sudden cardiac death in heart failure: what is the optimal pharmacologic strategy?
    Squire I
    Heart Fail Rev; 2004 Oct; 9(4):337-45; discussion 347-51. PubMed ID: 15886979
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.